RecruitingNot ApplicableNCT06015932

Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients

A Non-Randomized Translational Trial of Cognitive Behavioral Cancer Stress Management (CBCSM) and Its Effects on Cancer Distress


Sponsor

Mayo Clinic

Enrollment

400 participants

Start Date

Dec 20, 2017

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial tests how well cognitive behavioral cancer stress management (CBCSM) group sessions work to decrease psychological distress in cancer patients. CBCSM teaches patients how to recognize and reduce the impacts of cancer associated stress on the biological, psychological, and social life domains.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Eligible for the cognitive behavioral cancer stress management (CBCSM) clinical service
  • Cancer diagnosis with predicted survival > 1 year
  • Cancer treatment within past 1 year or treatment planning in progress
  • Age >= 18-years
  • Moderate distress screen, indicated by Impact of Event Scale-Revised (IES-R) score >= 14 or clinical judgment
  • Written informed research consent

Exclusion Criteria1

  • Inability to actively participate in and learn from group therapy (e.g., psychotic symptoms, neurological condition, personality pathology) as determined by clinical judgment in clinical consultation (Individual therapy or alternative group therapy will be offered)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCognitive Behavior Therapy

Participate in CBCSM group sessions

OTHERQuestionnaire Administration

Complete questionnaires


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06015932


Related Trials